#1 prescribed biologic
among allergists and pulmonologists1

BENEFITS WITH EVERY BREATH

Improve lung function so you or
your child can breathe better in
as little  as 2 weeks

Can reduce or completely  eliminate
oral steroid use in adults and
adolescents

SEE THE RESULTS

See clinical trial results by choosing
adults or adolescents (12+ years)
or children (6-11 years).

 

DUPIXENT was studied in 3 clinical trials with
more than 2,800 patients 12+ years with uncontrolled
moderate-to-severe asthma.
This indication was
approved by the
FDA on October 19, 2018.

DUPIXENT was studied in a clinical trial with more than 400
children 6 to 11 years with uncontrolled moderate-to-severe
asthma. This age group was approved by the FDA on
October 20, 2021.

DUPIXENT has been prescribed to over 70,000 uncontrolled moderate-to-severe asthma patients and counting!1,a,b

aNew adult and pediatric patients (6+ years of age and older) with uncontrolled moderate-to-severe eosinophilic or oral corticosteroid dependent asthma.
bIQVIA National Source of Business (NSOB) data as of June 2022.

IS YOUR ASTHMA
WELL CONTROLLED?

People often think their asthma or their child’s asthma is under control, but it may not be. So to help you or your child DU MORE with less asthma, it’s important to understand the current level of your or your child’s asthma control.

FIND A SPECIALIST
WHO TREATS ASTHMA

Use this HealthgradesTM tool to easily find nearby specialists with experience in treating children, teens, and adults with uncontrolled moderate-to-severe eosinophilic or oral steroid dependent asthma.

Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.

DUPIXENT MyWay ® COPAY CARD

The DUPIXENT MyWay Copay Card may help eligible patients cover the
out-of-pocket cost of DUPIXENT. If you're eligible, you can sign up and your card will be sent via email. Terms & Restrictions Apply.

SEE COPAY DETAILS

DUPIXENT MyWay also offers Nurse Educator Support, supplemental injection training online or in-person, and more.

SEE MORE INFORMATION

REAL PATIENT EXPERIENCES

View 4 patients’ journeys to DUPIXENT
and their struggles with
moderate-to-severe asthma.

HEAR THEIR STORIES

Marlena,
Real patient. Individual results may vary.

READ ABOUT DUPIXENT IN SPANISH

Learn more about moderate-to-severe
asthma, see how DUPIXENT can help,
and much more. Visit the Spanish
website for all things DUPIXENT.